At the Clinical Neuroimmunology Department, we offer comprehensive care for people with multiple sclerosis and other neurodegenerative diseases of the nervous system, such as myasthenia gravis, Guillain-Barré syndrome or chronic inflammatory demyelinating polyneuropathy. Located in the Multiple Sclerosis Centre of Catalonia (Cemcat), we are leaders in Catalonia in offering care to patients with multiple sclerosis, and are responsible for significant research and teaching activity.
At the Clinical Neuroimmunology Department, our mission is to improve the health and quality of life of people with neuroimmunological diseases according to their individual needs and choices. The key to achieving this is comprehensive care.
We have a multidisciplinary team of staff who work to offer early diagnosis, personalised treatments —to relieve symptoms and offer neurorehabilitation—, reduced number of hospital admissions, outpatient care and even home care, always actively including patients and their families.
In addition to our own staff, we establish links with professionals from different disciplines, such as neurologists, researchers, neuropsychologists, nursing staff, physiotherapists, speech therapists, occupational therapists and social workers, in order to offer the patient a comprehensive diagnosis with personalised treatment.
This multidisciplinary approach, coupled with personalised, precision medical decisions, results in extremely high-quality diagnosis and treatments adapted to each individual case.
Collaboration between the professionals involved takes place at weekly clinical sessions, where we discuss the initial visits and make decisions about the most appropriate treatments for each patient. This means all processes follow well-defined protocols.
Every year 3,000 patients visit us at the Clinical Neuroimmunology Department, with 500 initial visits annually, 7,000 subsequent visits and more than 2,500 day hospital visits.
The clinical monitoring of people with multiple sclerosis is the motivation of 90% of the research at our Department, which is reflected in the growing number of published articles and their impact over recent years. Our participation in the majority of the international clinical trials related to multiple sclerosis is also one of the main indicators of the extent of our research work.
The teaching activity of the Neuroimmunology Department covers undergraduate, postgraduate and continued education of professionals in the field of multiple sclerosis. It is also worth highlighting the master's programme in neuroimmunology that we organise and run.
The Multiple Sclerosis Centre of Catalonia, Cemcat, is a pioneering centre in the treatment of this neurodegenerative pathology and is led by Dr. Xavier Montalban. A leader in applying an overall view of patients and offering the most advanced treatments available.
Dr. Josep Sánchez de Toledo Codina, head of the Paediatric Haematology and Oncology Department, tells us about a Department that has laid the foundations for the specialism in Spain. He also remembers the evolution of transplants from haematopoietic stem cells and progenitors, from the beginning, buying the material at a shop in Barcelona city centre, to the more than 1,200 transplants that have now been performed.
Dr. Francesc Bosch, Head of the Haematology Department, talks about the complexity of the Department, which has turned Vall d’Hebron into a reference centre in haematology thanks to its commitment to transplants and the use of new treatments. The Clinical Trials Unit helps a lot, giving access to treatments for complex patients.
The Master's Degree in Biomedical and Translational Research is an official programme created to train researchers with the requisite combination of scientific knowledge and skills to contribute to the future success of biomedical research.
Fermín Fernández Álvarez, Porter Coordinator, explains the importance of the role these professionals play in the hospital. After 36 years at Vall d’Hebron, Fermín is a real master of the ways things are done. He says that a porter has to combine humility, discretion and safety with a single goal: that patients receive human and friendly treatment.